ArticleJournal of translational medicine2024

Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.

Giulia Pasello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.